Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Distribution
P/S (TTM)
0.4
Patterson Companies, Inc. specializes in distributing products essential for both dental and animal health sectors across the United States, Canada, and the United Kingdom. The company's operations are structured into three main divisions: Dental, Animal Health, and Corporate. The Dental segment supplies a wide array of expendable items such as infection control solutions, restorative materials, and instruments. It also provides both foundational and cutting-edge dental technology and equipment. Furthermore, this division offers comprehensive solutions designed to enhance practice efficiency, encompassing management software, e-commerce platforms, revenue cycle administration, patient interaction tools, and educational systems for clinicians and patients. Complementary services include software development and design, upkeep and servicing, and financial assistance for equipment acquisition. The Animal Health segment furnishes a broad spectrum of necessities, including biological agents, medications, immunizations, parasiticides, diagnostic tools, specialized diets (both prescription and over-the-counter), nutritional supplements, general supplies, equipment, and software. This segment also delivers various value-added services and markets its own exclusive product lines—Aspen, First Companion, and Patterson Veterinary—to serve veterinarians, livestock producers, and retail outlets. Through its Corporate segment, Patterson Companies facilitates financing for its clientele and markets various other distinct products. Its diverse customer base spans dentists, dental laboratories, healthcare institutions, and other medical practitioners, alongside veterinarians, animal care specialists, large-scale animal producers, and retailers specializing in animal health goods. The organization, which was established in 1877, was originally known as Patterson Dental Company before officially rebranding to Patterson Companies, Inc. in June 2004. Its corporate headquarters are situated in Saint Paul, Minnesota.
www.pattersoncompanies.comNo one on the platform currently holds PDCO.
No tracked institution reports a position in PDCO as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2024-10-18 | $0.2600 | 2024-11-01 |
| 2024-07-19 | $0.2600 | 2024-08-02 |
| 2024-04-18 | $0.2600 | 2024-05-03 |
| 2024-01-18 | $0.2600 | 2024-02-02 |
| 2023-10-19 | $0.2600 | 2023-11-03 |
No one on the platform has traded PDCO yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 11.7% | — | — | — | ||
| Rev. Growth % | 1.5% | 3.3% | ||||
| Profit Margin % | 2.8% | 0.2% | 1.8% | |||
| Free Cash Flow Margin % | -13.0% | -11.9% | -4.9% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is +3.7% on the P/E track.
At today's price, your expected annual return is +7.9% on the P/E track.
At today's price, your expected annual return is +11.5% on the P/E track.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $6.9B | +3.4% | $2.42 | $2.24–$2.61 | 12.9× | 2 |
| 2028 | $7.3B | +6.1% | $3.04 | $3.04–$3.04 | 10.3× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2025-02-26 | $0.62 | $0.43 | -30.6% |
| 2024-12-05 | $0.49 | $0.47 | -4.1% |
| 2024-08-28 | $0.32 | $0.24 | -25.0% |
| 2024-06-18 | $0.82 | $0.82 | +0.0% |
| 2024-02-28 | $0.60 | $0.59 | -1.7% |
| 2023-11-29 | $0.58 | $0.50 | -13.8% |
| 2023-08-30 | $0.40 | $0.40 | +0.0% |
| 2023-06-21 | $0.70 | $0.84 | +20.0% |
| $2.9B |
| — |
| MORFMorphic Holding, Inc. | $56.99 | +0.04% | $2.9B | — |
| MYOVMyovant Sciences Ltd. | $26.98 | -0.04% | $2.6B | — |
Source: Financial Modeling Prep · peers by sector/industry
$PDCO Patterson generates decent cash flow from a diversified customer base, but margin pressure and modest growth suggest this isn't exactly a rocket ship to riches. https://stratafinance.beehiiv.com/p/patterson
View on StockTwits ↗
$PDCO shareholders just cashed out at $31.35/share - a 49% premium locked in via acquisition. The company's now private under Patient Square Capital, with NASDAQ delisting effective immediately. While the exit provides relief from deteriorating fundamentals, public investors are now left watching from the sidelines. https://www.sec.gov/Archives/edgar/data/891024/000119312525083614/d904320d8k.htm
View on StockTwits ↗
$STRL $PDCO Sterling Infrastructure to replace Patterson Companies in S&P 600 on 4/17 Patient Square Capital is acquiring Patterson Companies in a deal expected to be completed soon, pending final closing conditions.
View on StockTwits ↗
Patterson Companies $PDCO acquired by Patient Square Capital - Shareholders to receive $31.35 cash per share owned - Shares of $PDCO to be delisted after the close of extended hours trading, tonight More Information : https://www.sec.gov/Archives/edgar/data/891024/000119312525070175/d900586dex991.htm
View on StockTwits ↗S&P600 Index Change today on market close Addition - $STRL Deletion - $PDCO (Acq.)
View on StockTwits ↗$STRL $PDCO Sterling Infrastructure to replace Patterson Companies in S&P 600 on 4/17 Patient Square Capital is acquiring Patterson Companies in a deal expected to be completed soon, pending final closing conditions.
View on StockTwits ↗
Wall St is expecting 0.81 EPS for $PDCO Q4 [Reporting 06/25 AMC] http://www.estimize.com/intro/pdco?chart=historical&metric_name=eps&utm_co
View on StockTwits ↗$PDCO Patterson Companies shareholders approve acquisition by Patient Square Patterson Companies announced that its shareholders approved at a special meeting the acquisition of Patterson by Patient Square Capital. Under the terms of the Agreement and Plan of Merger dated December 10, 2024, in connection with the merger contemplated thereby, Patterson shareholders will receive $31.35 in cash per share of common stock. Patterson expects the transaction to close later this month, subject to the satisfaction of certain customary closing conditions set forth in the Merger Agreement. Upon completion of the transaction, Patterson will become a privately held company, and its common stock will no longer be traded on the NASDAQ Global Select Market.
View on StockTwits ↗
$PDCO / Patient Square Capital LP - Shareholder Vote $PDCO
View on StockTwits ↗
$PDCO Dental and animal health distribution looking rough. Cost cuts help but equipment market weak. Watching for software segment recovery. Might trim position if Q4 doesn't show improvement. Great writeup: https://beyondspx.com/article/patterson-companies-pdco-a-dental-and-animal-health-powerhouse-navigating-evolving-markets
View on StockTwits ↗Wall St is expecting 0.86 EPS for $PDCO Q4 [Reporting 06/25 AMC] http://www.estimize.com/intro/pdco?chart=historical&metric_name=eps&utm_co
View on StockTwits ↗
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Patterson Companies Inc. Is that bullish or bearish? $PDCO #RsiOverbought #NASDAQ
View on StockTwits ↗
$PDCO - Patterson Companies Inc. Common Stock - 10Q - Updated Risk Factors PDCO faces significant risks with the proposed Merger, including potential delays, business disruptions, termination costs, and litigation challenges impacting stock price and operations. #Risk https://d-risk.ai/PDCO/10-Q/2025-02-26
View on StockTwits ↗
$PDCO Patterson Non-GAAP EPS of $0.43 misses by $0.19, revenue of $1.57B misses by $60M
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.